1
|
McDonald S, Rubin P, Phillips TL and Marks
LB: Injury to the lung from cancer therapy: Clinical syndromes,
measurable endpoints and potential scoring systems. Int J Radiat
Oncol Biol Phys. 31:1187–1203. 1995. View Article : Google Scholar : PubMed/NCBI
|
2
|
Robnett TJ, Machtay M, Vines EF, McKenna
MG, Algazy KM and McKenna WG: Factors predicting severe radiation
pneu-monitis in patients receiving definitive chemoradiation for
lung cancer. Int J Radiat Oncol Biol Phys. 48:89–94. 2000.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Hughes-Davies L, Tarbell NJ, Coleman CN,
Silver B, Shulman LN, Linggood R, Canellos GP and Mauch PM: Stage
IA-IIB Hodgkin's disease: Management and outcome of extensive
thoracic involvement. Int J Radiat Oncol Biol Phys. 39:361–369.
1997. View Article : Google Scholar : PubMed/NCBI
|
4
|
Cappuccini F, Eldh T, Bruder D, Gereke M,
Jastrow H, Schulze-Osthoff K, Fischer U, Köhler D, Stuschke M and
Jendrossek V: New insights into the molecular pathology of
radiation-induced pneumopathy. Radiother Oncol. 101:86–92. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Wynn TA: Integrating mechanisms of
pulmonary fibrosis. J Exp Med. 208:1339–1350. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Balli D, Ustiyan V, Zhang Y, Wang IC,
Masino AJ, Ren X, Whitsett JA, Kalinichenko VV and Kalin TV: Foxm1
transcription factor is required for lung fibrosis and
epithelial-to-mesenchymal transition. EMBO J. 32:231–244. 2013.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Pozharskaya V, Torres-González E, Rojas M,
Gal A, Amin M, Dollard S, Roman J, Stecenko AA and Mora AL: Twist:
A regulator of epithelial-mesenchymal transition in lung fibrosis.
PLoS One. 4:e7559–e7510. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hodge S, Holmes M, Banerjee B, Musk M,
Kicic A, Waterer G, Reynolds PN, Hodge G and Chambers DC:
Posttransplant bronchiolitis obliterans syndrome is associated with
bronchial epithelial to mesenchymal transition. Am J Transplant.
9:727–733. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Almeida C, Nagarajan D, Tian J, Leal SW,
Wheeler K, Munley M, Blackstock W and Zhao W: The role of alveolar
epithelium in radiation-induced lung injury. PLoS One.
8:e536282013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Mao H, Li Z, Zhou Y, Li Z, Zhuang S, An X,
Zhang B, Chen W, Nie J, Wang Z, et al: HSP72 attenuates renal
tubular cell apoptosis and interstitial fibrosis in obstructive
nephropathy. Am J Physiol Renal Physiol. 295:F202–F214. 2008.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Tanaka K, Tanaka Y, Namba T, Azuma A and
Mizushima T: Heat shock protein 70 protects against
bleomycin-induced pulmonary fibrosis in mice. Biochem Pharmacol.
80:920–931. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Hagiwara S, Iwasaka H, Matsumoto S,
Noguchi T and Yoshioka H: Association between heat stress protein
70 induction and decreased pulmonary fibrosis in an animal model of
acute lung injury. Lung. 185:287–293. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Niu P, Liu L, Gong Z, Tan H, Wang F, Yuan
J, Feng Y, Wei Q, Tanguay RM and Wu T: Overexpressed heat shock
protein 70 protects cells against DNA damage caused by ultraviolet
C in a dose-dependent manner. Cell Stress Chaperones. 11:162–169.
2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kawana K, Miyamoto Y, Tanonaka K, Han-no
Y, Yoshida H, Takahashi M and Takeo S: Cytoprotective mechanism of
heat shock protein 70 against hypoxia/reoxygenation injury. J Mol
Cell Cardiol. 32:2229–2237. 2000. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hirakawa T, Rokutan K, Nikawa T and Kishi
K: Geranylgeranylacetone induces heat shock proteins in cultured
guinea pig gastric mucosal cells and rat gastric mucosa.
Gastroenterology. 111:345–357. 1996. View Article : Google Scholar : PubMed/NCBI
|
16
|
Niwa Y, Nakamura M, Miyahara R, Ohmiya N,
Watanabe O, Ando T, Kawashima H, Itoh A, Hirooka Y and Goto H:
Geranylgeranylacetone protects against diclofenac-induced gastric
and small intestinal mucosal injuries in healthy subjects: A
prospective randomized placebo-controlled double-blind cross-over
study. Digestion. 80:260–266. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Liu J, Bao J, Hao J, Peng Y and Hong F:
HSP70 inhibits high glucose-induced Smad3 activation and attenuates
epithelial-to-mesenchymal transition of peritoneal mesothelial
cells. Mol Med Rep. 10:1089–1095. 2014.PubMed/NCBI
|
18
|
Zhang Y, Zhang X, Shan P, Hunt CR, Pandita
TK and Lee PJ: A protective Hsp70-TLR4 pathway in lethal oxidant
lung injury. J Immunol. 191:1393–1403. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kim KK, Kugler MC, Wolters PJ, Robillard
L, Galvez MG, Brumwell AN, Sheppard D and Chapman HA: Alveolar
epithelial cell mesenchymal transition develops in vivo during
pulmonary fibrosis and is regulated by the extracellular matrix.
Proc Natl Acad Sci USA. 103:13180–13185. 2006. View Article : Google Scholar : PubMed/NCBI
|
20
|
Adamson IY, Young L and Bowden DH:
Relationship of alveolar epithelial injury and repair to the
induction of pulmonary fibrosis. Am J Pathol. 130:377–383.
1988.PubMed/NCBI
|
21
|
Takeichi M: Cadherin cell adhesion
receptors as a morphogenetic regulator. Science. 251:1451–1455.
1991. View Article : Google Scholar : PubMed/NCBI
|